A unipapillary kidney is a very rare anomaly in humans. In this paper, we report on a case of a 47-year-old woman with end-stage kidney disease (ESKD) due to unipapillary kidney, who had been on hemodialysis for 20 years and who had successfully received deceased-donor kidney transplantation. The aim of this report is to present a case of a rare unipapillary kidney patient who underwent kidney transplantation without any urological complications. Our results suggest that kidney transplantation may be an effective renal replacement therapy for patients with ESKD due to unipapillary kidney.

1.
Yosypiv IV: Congenital anomalies of the kidney and urinary tract: a genetic disorder? Int J Nephrol 2012; 2012: 909083.
2.
Kaneto H, Metoki R, Fukuzaki A, Kuji S, Ishikawa H, Orikasa S: Unicalyceal kidney associated with ureteral anomalies. Eur Urol 1997; 32: 328–331.
3.
Smith SJ, Cass AS, Aliabadi H, Ambani N, Gleich P, Winter RB: Unipapillary kidney: a case report and literature review. Urol Radiol 1984; 6: 43–47.
4.
Morimoto S, Sangen H, Takamatsu M, Kitagawa M, Fujinaga T, Kitamura S, Ohkawa T: Solitary calix in siblings. J Urol 1979; 122: 690–691.
5.
Neal A, Murphy L: “Uni-papillary kidney” an unusual developmental abnormality of the kidney. J Coll Radiol Aust 1960; 4: 81–83.
6.
Jolly BB, Jolly M: Unipapillary kidney: a case report. Urol Int 1995; 54: 175–176.
7.
Toppercer A: Unipapillary human kidney associated with urinary and genital abnormalities. Urology 1980; 16: 194–196.
8.
Demos TC, Malone A, Schuster GA: Unicaliceal kidney associated with posterior urethral (1983) valves . J Urol 1983; 129: 1034–1035.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.